OBJECTIVE: Inflammation contributes to the development of peripheral artery disease (PAD) and may contribute to intermittent claudication by adversely affecting vascular and skeletal muscle function. We explored the association of inflammation to maximal walking time (MWT) in patients with claudication. METHODS:Circulating inflammatory biomarkers, including tumor necrosis factorα (TNF-α), C-reactive protein (CRP), interleukin-6 (IL-6), and soluble intercellular adhesion molecule 1 (sICAM), were measured in 75 subjects with intermittent claudication as well as in 43 healthy subjects. Real-time polymerase chain reaction was used to quantify mRNA expression of TNF-α, IL-6, interferon-γ, and CD36 from peripheral blood monocytes. Treadmill testing was performed in PAD subjects to assess MWT. RESULTS: Compared with healthy subjects, PAD subjects had higher levels of circulating TNF-α (P < .0001), CRP (P = .003), sICAM (P < .0001), and IL-6 (P < .0001). Expression of both IL-6 (P = .024) and CD36 (P = .018) was greater in PAD subjects than in healthy subjects. Among subjects with PAD, higher gene expression of TNF-α was associated inversely with MWT (P = .01). MWT was also associated inversely with greater levels of circulating TNF-α (P = .028), CRP (P = .024), IL-6 (P = .03), and sICAM (P = .018). CONCLUSIONS: Systemic inflammation, as indicated by TNF-α inflammatory gene expression in peripheral blood monocytes and by circulating biomarker levels, is associated with impairment in walking time in patients with PAD and intermittent claudication.
RCT Entities:
OBJECTIVE:Inflammation contributes to the development of peripheral artery disease (PAD) and may contribute to intermittent claudication by adversely affecting vascular and skeletal muscle function. We explored the association of inflammation to maximal walking time (MWT) in patients with claudication. METHODS: Circulating inflammatory biomarkers, including tumor necrosis factor α (TNF-α), C-reactive protein (CRP), interleukin-6 (IL-6), and soluble intercellular adhesion molecule 1 (sICAM), were measured in 75 subjects with intermittent claudication as well as in 43 healthy subjects. Real-time polymerase chain reaction was used to quantify mRNA expression of TNF-α, IL-6, interferon-γ, and CD36 from peripheral blood monocytes. Treadmill testing was performed in PAD subjects to assess MWT. RESULTS: Compared with healthy subjects, PAD subjects had higher levels of circulating TNF-α (P < .0001), CRP (P = .003), sICAM (P < .0001), and IL-6 (P < .0001). Expression of both IL-6 (P = .024) and CD36 (P = .018) was greater in PAD subjects than in healthy subjects. Among subjects with PAD, higher gene expression of TNF-α was associated inversely with MWT (P = .01). MWT was also associated inversely with greater levels of circulating TNF-α (P = .028), CRP (P = .024), IL-6 (P = .03), and sICAM (P = .018). CONCLUSIONS:Systemic inflammation, as indicated by TNF-α inflammatory gene expression in peripheral blood monocytes and by circulating biomarker levels, is associated with impairment in walking time in patients with PAD and intermittent claudication.
Authors: Aruna D Pradhan; Sanjay Shrivastava; Nancy R Cook; Nader Rifai; Mark A Creager; Paul M Ridker Journal: Circulation Date: 2008-01-28 Impact factor: 29.690
Authors: William R Hiatt; Alan T Hirsch; Mark A Creager; Sanjay Rajagopalan; Emile R Mohler; Christie M Ballantyne; Judith G Regensteiner; Diane Treat-Jacobson; Rita A Dale; Thom Rooke Journal: Vasc Med Date: 2010-03-08 Impact factor: 3.239
Authors: A C Alibegovic; M P Sonne; L Højbjerre; J Bork-Jensen; S Jacobsen; E Nilsson; K Faerch; N Hiscock; B Mortensen; M Friedrichsen; B Stallknecht; F Dela; A Vaag Journal: Am J Physiol Endocrinol Metab Date: 2010-08-24 Impact factor: 4.310
Authors: Christopher D Owens; Paul M Ridker; Michael Belkin; Allen D Hamdan; Frank Pomposelli; Frank Logerfo; Mark A Creager; Michael S Conte Journal: J Vasc Surg Date: 2006-11-21 Impact factor: 4.268
Authors: Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel Journal: Circulation Date: 2006-03-21 Impact factor: 29.690
Authors: Hassan Albadawi; A Aria Tzika; Christian Rask-Madsen; Lindsey M Crowley; Michael W Koulopoulos; Hyung-Jin Yoo; Michael T Watkins Journal: J Surg Res Date: 2016-06-08 Impact factor: 2.192
Authors: Michael J Zhang; Brian E Sansbury; Jason Hellmann; James F Baker; Luping Guo; Caitlin M Parmer; Joshua C Prenner; Daniel J Conklin; Aruni Bhatnagar; Mark A Creager; Matthew Spite Journal: Circulation Date: 2016-08-09 Impact factor: 29.690
Authors: Pawel Maga; Tomasz P Mikolajczyk; Lukasz Partyka; Marek Krzanowski; Krzysztof P Malinowski; Rafal Nizankowski Journal: Biomed Res Int Date: 2016-10-13 Impact factor: 3.411
Authors: Moritz Wildgruber; Teresa Aschenbrenner; Heiko Wendorff; Maria Czubba; Almut Glinzer; Bernhard Haller; Matthias Schiemann; Alexander Zimmermann; Hermann Berger; Hans-Henning Eckstein; Reinhard Meier; Walter A Wohlgemuth; Peter Libby; Alma Zernecke Journal: Sci Rep Date: 2016-12-19 Impact factor: 4.379
Authors: Pawel Maga; Tomasz P Mikolajczyk; Lukasz Partyka; Mateusz Siedlinski; Mikolaj Maga; Marek Krzanowski; Krzysztof Malinowski; Kevin Luc; Rafal Nizankowski; Deepak L Bhatt; Tomasz J Guzik Journal: Clin Immunol Date: 2018-06-21 Impact factor: 3.969